Safety and Efficacy of Flecainide in the Treatment of Symptomatic Children With Wolff-Parkinson-White Syndrome
✍ Scribed by Francisco Núñez; Ricardo Ruiz-Granell; Cecilia Martínez-Costa; Salvador Morell; Juan Brines
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 147 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0172-0643
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To study the age-related differences in Wolff-Parkinson-White syndrome an elderly group of 20 patients aged 40-65 years was compared to a younger group of 26 patients aged 18-39 years with respect to clinical profile and electrophysiological characteristics. The two groups were comparable in terms o
## Abstract The objective of our study was to assess the efficacy and safety of donepezil in young adults with Down syndrome (DS) but no evidence of Alzheimer disease (AD). A 12‐week, randomized, double‐blind, placebo‐controlled study with a 12‐week, open‐label extension was conducted. The interven